文献速递其他结缔组织病

T1 mapping心脏磁共振常检出系统性硬化症患者亚临床弥漫性心肌纤维化

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
PubMed 文献 · Semin Arthritis Rheum · 2019-06-19

T1升高与临床、超声或抗体谱均无相关性。

要点

  • SSc患者中native T1 mapping检出左室T1升高(潜在DMF)的比例为50%。
  • T1升高与心血管危险因素、缺血性心脏病、临床参数、超声参数及抗体谱均无相关性。

核心结论

  • native T1 mapping可在50%的SSc患者中检出左室T1升高(潜在DMF),其中三分之一常规筛查(含标准CMR)正常。

主要发现

  • T1升高组与正常T1组CMR心脏功能参数相似。
  • T1升高组中18例(50%)超声心动图正常。
  • T1升高组与正常T1组心血管危险因素及缺血性心脏病相似。
  • T1升高与任何临床、超声心动图参数或抗体谱均无相关性。

关键数值与推荐

  • T1升高定义为native T1 mapping检出左室T1升高,平均T1 1097±14 ms。
  • SSc分类采用ACR/EULAR分类标准。

临床怎么用

  • 对SSc患者可考虑将native T1 mapping纳入常规随访CMR,以早期检出常规筛查阴性的潜在DMF。
  • T1升高与常规临床、超声及抗体谱无相关性,提示不能仅凭常规筛查排除亚临床心肌受累。

局限性

  • 原文指出需未来进一步研究确认将native T1 mapping纳入常规随访以早期检出SSc不良心脏受累的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: cardiac involvement is the second most frequent systemic sclerosis (SSc) related cause of death. It remains mostly asymptomatic in the early stage and is underdiagnosed with routine screening. Cardiac magnetic resonance imaging (CMR) could improve cardiac assessment of patients and noteworthily, new sequences allow the detection of diffuse myocardial fibrosis (DMF) by native T1 mapping. The aim of this study was to determine the prevalence of cardiac involvement by CMR native T1 mapping and its correlation with echocardiography data and non-cardiac manifestations in SSc patients. METHODS: patients fulfilling the ACR/EULAR classification criteria for SSc were prospectively included between 2014 and 2016. They underwent CMR at 1.5T, including native T1 and T2 mapping, and Late Gadolinium Enhancement (LGE) as a part of routine follow up. Routine biological tests (mainly BNP and CRP) were centralized in the hospital laboratory. RESULTS: seventy-two unselected patients were included. Thirty six patients (50%) had elevated T1 (ET1) (mean T1 1097±14 ms). CMR cardiac functional parameters were similar in ET1 and normal T1 (NT1). Echocardiography was normal in 18 (50%) of ET1. ET1 and NT1 groups were similar for cardiovascular risk factors and ischemic heart disease. ET1 was not correlated with any clinical or echocardiographic parameter or antibody profile. Thirty-six percent of patients with ET1 had no cardiac symptoms, normal echocardiography and CMR LVEF, and no LGE. CONCLUSION: native T1 mapping detects left ventricular ET1 (potential DMF) in 50% of patients with SSc and a third of them had a normal conventional screening including standard CMR. In the future, further studies are needed to confirm the benefit of use of native T1 mapping as a part of routine follow up to detect earlier pejorative cardiac involvement in SSc patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Poindron V, Chatelus E, Canuet M, et al. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients. Semin Arthritis Rheum. 2019. PMID: 31301817. doi:10.1016/j.semarthrit.2019.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。